Nucleic Acid Therapeutics Market Size And Share

Report Code : TIPRE00027648
Category : Life Sciences

No. of Pages : 150

Buy Now

Marktgröße und Marktanteil von Nukleinsäuretherapeutika bis 2025 – 2031

Buy Now

Nucleic Acid Therapeutics Market Report Analysis

Nucleic Acid Therapeutics Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

Alnylam Pharmaceuticals, Inc.
Silence Therapeutics plc
Arbutus Biopharma Corporation
Genzyme (Sanofi)
Ionis Pharmaceuticals
Sarepta Therapeutics
Benitec Biopharma Inc.
Arrowhead Pharmaceuticals
Biogen, Inc.

Regional Overview

Nordamerika
Europa
Asien-Pazifik
Süd- und Mittelamerika
Naher Osten und Afrika

Market Segmentation

By Typ

Antagomir und RNA-Schwamm
Antisense-Oligonukleotid-Therapie
gesperrte Nukleinsäure
Peptid-Nukleinsäure-Oligo
RNAi-Therapie
Triplex-bildendes Oligonukleotid.

By Anwendung

genetische Störungen
Autoimmunerkrankungen

By Endbenutzer

Forschungsinstitute
Krankenhäuser und Kliniken.

By Geographie

Nordamerika
Europa
Asien-Pazifik
Süd- und Mittelamerika